NASDAQ:AZRX

AzurRx BioPharma, Inc Earning Date

USA |NASDAQ |USD

AZRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 16, 2021 (est) Sep 30, 2021 - $-0.16 $-0.47
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 16, 2021 (est) Sep 30, 2021 - $0.00 $0.00

Azurrx Biopharma, Inc's next estimated earnings date (based on same quarter last year's date) is Nov 16, 2021 for the fiscal quarter ending Sep 30, 2021.

AZRX Earnings Date & History Chart

AZRX Earnings & Revenue Forecast

AZRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.83 $-1.05 $-0.60
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-4.37 $-6.80 $-3.10
Dec 2022 4 $-3.72 $-5.29 $-2.50

AZRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.07 $-0.07 $-0.07
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-0.40 $-0.36 $-0.29
Dec 2022 0 / 1 $-0.29 $-0.27 $-0.28

AZRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Dec 2022 1 $0.00 $0.00 $0.00

AZRX Earnings Date & Revenue History

AZRX Earnings History

|
Show More
Show More

AZRX Revenue History

|
Show More
Show More

Azurrx Biopharma, Inc Next Earnings Date & Report

AZRX Aug 2021 (FQ) Earnings Date & Report Preview

AZRX's next estimated earnings date (based on same quarter last year's report date) is Nov 16, 2021 for the fiscal quarter ending Sep 30, 2021.

Azurrx Biopharma, Inc Previous Earnings Dates & Reports

AZRX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Azurrx Biopharma, Inc's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

AZRX's earnings per share (EPS) was $-0.16, beating the consensus analysts forecast of $-0.75 by 78.67%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 14.29%, and higher than the same period a year before (Jun 2020) by -5.88%.

Revenues were $0.00.

The company reported a net income of $-9.28M.

Free cash flow for the quarter was $-14.70M , compared to $-5.07M last quarter and $-1.34M a year before.

AZRX ended the quarter with $543.81K in total debt, an increase of 32.52% compared to the previous quarter, and a decrease of -90.16% compared to the same quarter a year before.

AZRX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Azurrx Biopharma, Inc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

AZRX's earnings per share (EPS) was $-1.15, missing the consensus analysts forecast of $-0.90 by 27.78% , and lower than the previous year's EPS (Dec 2019) by 64.29%.

Revenues were $0.00.

The company reported a net income of $-32.67T.

Azurrx Biopharma, Inc reported a free cash flow of $-11.23M for its fiscal year, compared to $-14.06M a year ago.